Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		136,959,446
Beginning balance at Dec. 31, 2024	$ 1,150,385	$ 14	$ 1,911,872	$ (1,717)	$ (759,784)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		1,011,628
Exercise of stock options (in shares)		92,624
Exercise of stock options	598		598
Stock-based compensation	14,059		14,059
Other comprehensive loss	(258)			(258)
Net loss	(120,965)				(120,965)
Ending balance (in shares) at Mar. 31, 2025		138,063,698
Ending balance at Mar. 31, 2025	$ 1,043,819	$ 14	1,926,529	(1,975)	(880,749)
Beginning balance (in shares) at Dec. 31, 2025	139,474,954	139,474,954
Beginning balance at Dec. 31, 2025	$ 765,276	$ 14	1,965,090	(2,057)	(1,197,771)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with a public offering (in shares)		20,294,117
Issuance of common stock in connection with a follow-on public offering, net of issuance cost of $10,150	162,349	$ 2	162,347
Vesting of restricted common stock (in shares)		1,388,052
Vesting of restricted common stock	0
Exercise of stock options (in shares)		76,935
Exercise of stock options	174		174
Stock-based compensation	12,087		12,087
Other comprehensive loss	(1,426)			(1,426)
Net loss	$ (125,695)				(125,695)
Ending balance (in shares) at Mar. 31, 2026	161,234,058	161,234,058
Ending balance at Mar. 31, 2026	$ 812,765	$ 16	$ 2,139,698	$ (3,483)	$ (1,323,466)